Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0SC3W
|
||||
| Former ID |
DNC006048
|
||||
| Drug Name |
Bis-((-)-N-propargylmorphinan-3-yl) sebacoylate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527951] | ||
| Formula |
C48H60N2O4
|
||||
| Canonical SMILES |
C#CCN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC(=O)CCCCCCCCC(=O)OC<br />5=CC6=C(CC7C8C6(CCCC8)CCN7CC#C)C=C5
|
||||
| InChI |
1S/C48H60N2O4/c1-3-27-49-29-25-47-23-13-11-15-39(47)43(49)31-35-19-21-37(33-41(35)47)53-45(51)17-9-7-5-6-8-10-18-46(52)54-38-22-20-36-32-44-40-16-12-14-24-48(40,42(36)34-38)26-30-50(44)28-4-2/h1-2,19-22,33-34,39-40,43-44H,5-18,23-32H2/t39?,40?,43-,44-,47-,48-/m1/s1
|
||||
| InChIKey |
CMJNSGDVJLNRPB-TXEWOLIYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [527951] | |
| Kappa-type opioid receptor | Target Info | Inhibitor | [527951] | ||
| Mu-type opioid receptor | Target Info | Inhibitor | [527951] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||